Digoxin Micronized

Digoxin Micronized
Product Description

Filings: US-DMF, CEP, C-DMF, J-DMF, K-DMF, CADIFA*
*under submission/approval

C2 PHARMA provides a wide range of active pharmaceutical ingredients (APls) and complex chemical compounds obtained from synthetic and natural origins which includes Digoxin.

C2 PHARMA is the only API manufacturer able to offer a fully redundant dual-source of Digoxin API produced at two different sites, one of which is in Europe.

Digoxin is widely used in the treatment of various heart conditions, namely atrial fibrillation, atrial flutter and sometimes heart failure that cannot be controlled by other medication. Contact us for more information.

Read more Show less

C-squared PHARMA Limited

  • IE
  • 2015
    On CPHI since
  • 25 - 49
    Employees
Company types
Distributor/Import Export
Manufacturer/Innovator
View company profile
Categories
more categories Show less
Specifications
  • CAS Registry Number
    20830-75-5
More specifications Fewer specifications

C-squared PHARMA Limited

  • IE
  • 2015
    On CPHI since
  • 25 - 49
    Employees
Company types
Distributor/Import Export
Manufacturer/Innovator
View company profile

More Products from C-squared PHARMA Limited (12)

  • Atropine Sulfate

    Product Atropine Sulfate

    Filings: US-DMF, CEP, C-DMF*, K-DMF, T-DMF, MX, CADIFA*

    *under submission/approval
    C2 PHARMA provides a wide range of active pharmaceutical ingredients (APls) and complex chemical compounds obtained from synthetic and natural origins which includes Atropine Sulfate.

    Atropin...
  • Bimatoprost

    Product Bimatoprost

    Filings: US-DMF, C-DMF*, K-DMF*, ASMF, Canadian-DMF*

    *under submission/approval
    C2 PHARMA provides a wide range of active pharmaceutical ingredients (APls) and complex chemical compounds obtained from synthetic and natural origins which includes Bimatoprost. As 0.03% ophthalmic solution it is...
  • Brimonidine Tartrate

    Product Brimonidine Tartrate

    Filings: US-DMF, CEP, C-DMF*, K-DMF, ASMF 

    *under submission/approval
     
    C2 PHARMA provides a wide range of active pharmaceutical ingredients (APls) and complex chemical compounds obtained from synthetic and natural origins which includes Brimonidine Tartrate. As 0.2% ophthalmic solut...
  • Cyclopentolate Hydrochloride

    Product Cyclopentolate Hydrochloride

    Filings: US-DMF, CEP, C-DMF

    *under submission/approval

    C2 PHARMA provides a wide range of active pharmaceutical ingredients (APls) and complex chemical compounds obtained from synthetic and natural origins which includes Cyclopentolate Hydrochloride.

    It is used to cause my...
  • Digoxin

    Product Digoxin

    Filings: US-DMF, CEP, C-DMF, J-DMF, K-DMF

    *Under submission/approval

    C2 PHARMA provides a wide range of active pharmaceutical ingredients (APls) and complex chemical compounds obtained from synthetic and natural origins which includes Digoxin.


    C2 PHARMA is the only API manu...
  • Homatropine Hydrobromide

    Product Homatropine Hydrobromide

    Filings: US-DMF, CEP*

    *under submission/approval
    C2 PHARMA provides a wide range of active pharmaceutical ingredients (APls) and complex chemical compounds obtained from synthetic and natural origins which includes Homatropine Hydrobromide.  
     
    Homatropine Hydrobromide...
  • Homatropine Methylbromide

    Product Homatropine Methylbromide

    Filings: US-DMF, CEP, T-DMF, CADIFA*

    *under submission/approval
    C2 PHARMA provides a wide range of active pharmaceutical ingredients (APls) and complex chemical compounds obtained from synthetic and natural origins which includes Homatropine Methylbromide. 
     
    Homatropine M...
  • Latanoprost

    Product Latanoprost

    Filings: US-DMF, CEP*, C-DMF, K-DMF, T-DMF

    *under submission/approval
    C2 PHARMA provides a wide range of active pharmaceutical ingredients (APls) and complex chemical compounds obtained from synthetic and natural which includes Latanoprost. It is used as a 0.005% ophthalmic solution for the...
  • Pilocarpine Hydrochloride

    Product Pilocarpine Hydrochloride

    Filings: US-DMF, CEP, C-DMF*, K-DMF, T-DMF, I-DMF*

    *under submission/approval
    C2 PHARMA provides a wide range of active pharmaceutical ingredients (APls) and complex chemical compounds obtained from synthetic and natural origins which includes Pilocarpine Hydrochloride.

    Pilocarpine ...
  • Naphazoline Hydrochloride

    Product Naphazoline Hydrochloride

    Filings: US-DMF*, CEP*, CADIFA*

    *under submission/approval

    C2 PHARMA provides a wide range of active pharmaceutical ingredients (APls) and complex chemical compounds obtained from synthetic and natural origins which includes Naphazoline Hydrochloride.

    It is...
  • Pilocarpine Nitrate

    Product Pilocarpine Nitrate

    Filings: CEP, C-DMF, I-DMF*

    *under submission/approval


    C2 PHARMA provides a wide range of active pharmaceutical ingredients (APls) and complex chemical compounds obtained from synthetic and natural origins which includes Pilocarpine Nitrate.

    Pilocarpine Nitrate is used topically ...
  • Tropicamide

    Product Tropicamide

    Filings: US-DMF, CEP, J-DMF*, C-DMF*, J-DMF*

    *under submission/approval


    C2 PHARMA provides a wide range of active pharmaceutical ingredients (APls) and complex chemical compounds obtained from synthetic and natural origins which includes Tropicamide. 
     
    As a 0.5% and 1% t...

C-squared PHARMA Limited resources (2)

  • C2 PHARMA Expands Ophthalmic API Portfolio with Naphazoline Hydrochloride Launch

    News C2 PHARMA Expands Ophthalmic API Portfolio with Naphazoline Hydrochloride Launch

    C2 PHARMA, a global provider of ophthalmic and niche active pharmaceutical ingredients (APIs), has launched its latest API, Naphazoline Hydrochloride. The validation campaign for Naphazoline HCL was completed in June 2024. A Certificate of Suitability (CEP) is under approval while the US-Drug Master File (US-DMF) is planned for submission by November 2024 and the API dossier for Brazil (DIFA) in December 2024.
    16 Sep 2024
  • Ophthlamic Buyers Guide x PharmaSource

    Brochure Ophthlamic Buyers Guide x PharmaSource

    As the global leader in Ophthalmic APIs, C2 PHARMA was asked to participate in Pharmasource’s buyer guide focused on Ophthalmics.